Pirfenidone for idiopathic pulmonary fibrosis: analysis of pooled data from three multinational phase 3 trialsPaul W. Noble, Talmadge E. King, Ian Glaspole et al.|European Respiratory Journal|2015Cited by 462
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D. Nathan, Paul W. Noble, Carlo Albera et al.|The Lancet Respiratory Medicine|2016Cited by 331
Detection and Early Referral of Patients With Interstitial Lung AbnormalitiesGary M. Hunninghake, Jonathan Goldin, Michel Kadoch et al.|CHEST Journal|2021Cited by 56
A Randomized, Embedded, Multifactorial Adaptive Platform trial for ILD (REMAP-ILD): The conceptual designTejaswini Kulkarni, Gísli Jenkins, Letícia Kawano-Dourado et al.|Unknown|2023Cited by 2